Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood-Interstitial Fluid Glucose Gap: A Novel Indicator for Assessing Metabolic Status and Mortality Risk in Critically Ill Patients

NCT07240103 is registered in ClinicalTrials.gov with Chinese Medical Association as lead sponsor.

NCT NCT07240103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07240103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood-Interstitial Fluid Glucose Gap: A Novel Indicator for Assessing Metabolic Status and Mortality Risk in Critically Ill Patients
Lead sponsor
Chinese Medical Association
Phase
Observational
Overall status
Completed
Start date
July 13, 2023
Completion date
October 1, 2025
Enrollment
140 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, metabolism disorders